ArticlePharmaceuticals (Basel, Switzerland)2022

Design, Synthesis and Evaluation of Fused Bicyclo[2.2.2]octene as a Potential Core Scaffold for the Non-Covalent Inhibitors of SARS-CoV-2 3CL

Barbara Herlah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.